PORT ST. LUCIE, Fla. - TelAve -- Florida-based KindSoft LLC today announced that its KidneyKind iOS and Apple Watch app is now available on the Apple App Store in five countries: the United States, Canada, the United Kingdom, Ireland, and Australia. A Japanese App Store release is currently in App Review.

KidneyKind is a companion app for people living with chronic kidney disease, on dialysis, or navigating kidney transplantation. It was built by Mike McGarry, a peritoneal dialysis patient who designed the app around the realities of his own treatment. Unlike clinic-tied patient portals or generic health trackers, KidneyKind is purpose-built for the kidney patient experience: dialysis logging for both peritoneal and hemodialysis modalities, lab tracking with kidney-specific reference ranges, fluid intake and vitals, medications, appointments, care team contacts, and a guided transplant evaluation journey.

The transplant journey adapts to the patient's country of care, mapping the pathway for the U.S. UNOS system, the Canadian Transplant Registry, the UK NHS Blood and Transplant service, Ireland's National Renal Transplant Programme at Beaumont Hospital, Australia's OrganMatch and DonateLife services, and Japan's Japan Organ Transplant Network.

More on TelAve News

• Omnitronics Unveils 100% Software omniGateDMR and omniGateP25 RoIP Gateways
• KRE PRIME Launches Adaptive Convertible Jumpsuit
• USA Med Bed Helping Home Care Patients with Refurbished Hill Rom Hospital Beds
• Sobreseimiento de Nicolás dos Santos y Jorge Méndez expone demandas millonarias a Paraguay y boicot a la Hidrovía
• CAPHRA warns Southeast Asia not to repeat Australia's nicotine policy failure

McGarry's nephrologist reviewed the app in clinic in April 2026, calling it easier to understand at a glance than other software and noting that a clinician could look at the phone and know what is going on in three minutes. That clinical readability is core to KindSoft's design philosophy, which the company describes as dignity-first software for high-stakes contexts.

KidneyKind is available as a free download with a 14-day free trial of full features. Subscriptions start at USD 6.99 per month, with quarterly, six-month, and annual options, and local-currency pricing in each supported territory. The app is built natively on Apple platforms with iCloud-backed sync, no third-party analytics, and no third-party servers operated by the company. KidneyKind is available now on the Apple App Store and at https://kidneykindapp.com.